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Abstract 
 Enzyme immunoassays (EIAs) are widely used to measure salivary testosterone. However, little 
is known about how accurately different EIAs assess testosterone, partially because estimates across 
various EIAs differ considerably. We compared testosterone concentrations across EIAs of three 
commonly used manufacturers (DRG International, Salimetrics, and IBL International) to liquid 
chromatography tandem mass spectrometry (LC-MS/MS). Relative to EIAs from Salimetrics and IBL 
International, EIAs supplied by DRG International provided the closest approximation to LC-MS/MS 
testosterone concentrations with the least measurement error. Additionally, EIAs largely overestimated 
testosterone in women’s saliva samples with higher testosterone concentrations, relative to men’s. 
Examining our results and comparing them to existing data revealed that testosterone EIAs had decreased 
linear correspondence with LC-MS/MS in comparison to cortisol EIAs. Overall, this paper provides 
researchers with information to better measure testosterone in their research and more accurately compare 
testosterone measurements across different methods. 
Keywords: Salivary Testosterone, Immunoassays, Liquid Chromatography, Mass Spectrometry, 
Measurement 
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A comparison of salivary testosterone measurement using immunoassays and tandem mass spectrometry 
1. Introduction 
 Testosterone—an androgenic steroid hormone and end product of the hypothalamic-pituitary-
gonadal axis—has been increasingly studied by psychoneuroendocrinology researchers for its 
associations with behaviors and psychological processes implicated in social status and affiliation, such as 
dominance (e.g., Mazur & Booth, 1998), risk-taking (e.g., Apicella et al., 2014), romantic relationships 
(Edelstein et al., 2014), sexual behavior (e.g., Puts et al., 2015), aggression (e.g., Carré et al., 2014), and 
competition (e.g., Mehta et al., 2015). To assess testosterone levels, researchers across disciplines have 
adopted the use of salivary hormone analysis. This technique has several advantages, including ease of 
collection, cost-effectiveness, non-invasiveness, and the ability to assess salivary testosterone changes 
over short intervals of time.  
1.1. Assessment of Salivary Hormones through EIAs 
Salivary hormone concentrations are frequently measured with enzyme immunoassays (EIAs). 
EIAs are cost-effective and convenient, making them attractive tools for measuring hormones like 
testosterone. Although many companies manufacture assay kits for commercial use, recent work suggests 
that these different kits vary in concentration predictions for the same hormones (e.g., Taieb et al., 2003; 
Baecher et al., 2013; Crewther et al., 2013). Some potential reasons for differences in the estimation of 
hormone levels across kits include differing levels of sensitivity and specificity across the range of 
hormonal concentrations, with the lowest and highest concentrations being most prone to quantification 
errors (Schultheiss & Stanton, 2009). This difference presents a potential obstacle to the accurate 
assessment of testosterone, especially in populations with lower levels of testosterone such as women and 
children (Rosner et al., 2007). Cross-reactivity acts as another potential source of inaccuracy in hormone 
assessment (i.e., inflation) with EIAs. Cross-reactivity occurs when chemically similar compounds are 
measured in addition to the hormone of interest because these compounds bind to the same receptors as 
the target analyte. Testosterone EIAs are found to cross-react with other steroids (Chattoraj, 1976) and 
biological agents (e.g., sex hormone-binding globulin; Pugeat et al., 1981). Consistent with this research 
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on testosterone measurement, previous studies of cortisol have revealed differences in predicted salivary 
cortisol concentrations across assay kits (e.g., Baecher et al., 2013; Miller et al., 2013). These differences 
have been attributed to differing specifications of kits and cross-reactivity in EIAs.   
Despite the limitations of EIA, its relative ease and cost-effectiveness has made it a popular 
technique for hormone measurement. Thus, it is critical to assess the validity of EIAs in the measurement 
of salivary testosterone. To do so, we propose to compare popular commercially available testosterone 
EIAs with testosterone measured using liquid chromatography tandem mass spectrometry (LC-MS/MS), 
an alternative measurement technique for salivary hormone analysis that is free from some of the 
limitations posed by EIAs. 
1.2. Assessing the Validity of EIAs with Liquid Chromatography Tandem Mass Spectrometry 
The use of LC-MS/MS as an analytical tool has become popular in a growing number of 
laboratories seeking to quantify hormone concentrations (Soldin & Soldin, 2009; Field, 2013; Keefe et 
al., 2014). The technique demonstrates impressive analytical specificity and is argued to be free of many 
of the limitations of IAs (e.g. matrix interference; Hoofnagle & Wener, 2009). Although the financial and 
logistical requirements of LC-MS/MS limit its widespread use, the technique is a sensitive reference 
measure, allowing for both the identification and quantification of compounds by combining the physical 
separation capacity of liquid chromatography with the mass analysis capability of mass spectrometry 
(Star-Weinstock et al., 2012; Turpeinen et al., 2012; Keevil, 2013). Miller and colleagues (2013) recently 
evaluated the validity and agreement between various immunoassays and LC-MS/MS assessing cortisol 
concentrations in adult saliva samples. Although one EIA (Demeditec) has been found to have a strong 
correlation with LC-MS/MS testosterone (Yasuda et al., 2008), no published research to our knowledge 
has directly compared how multiple EIA assessments of salivary testosterone are associated with those of 
LC-MS/MS. 
1.3. Overview of the Current Research 
In an effort to bridge this gap, in the present study, we compared the accuracy of salivary 
testosterone measured via EIAs from Salimetrics, DRG International, and IBL International (hereby DRG 
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and IBL, respectively) to LC-MS/MS. We also compared the shape, spread, and center of the 
concentration distributions from different EIAs with LC-MS/MS to examine how closely these 
commercially manufactured EIAs approximate LC-MS/MS concentrations of testosterone. As a 
secondary goal, we also estimated salivary cortisol concentrations with LC-MS/MS to investigate if 
associations with testosterone and LC-MS/MS cortisol varied as a function of the testosterone EIA used. 
2. Methods 
2.1. Samples 
 One hundred saliva samples obtained via passive drool were drawn from a large pool previously 
assayed for salivary testosterone using Salimetrics EIAs (1-2402, Salimetrics, State College, PA, USA; M 
testosterone = 103.11 pg/mL; SD = 63.41 pg/mL) and cortisol using IBL EIAs (RE52631, IBL 
International, Toronto, ON, CA). All procedures were conducted with the adequate understanding and 
written consent of the participants in accordance with the Declaration of Helsinki. Samples from this large 
pool were collected over the course of the 2012 United States Presidential Election (Prasad et al., in prep; 
see supplemental materials for methodological details). To ensure adequate volume for analysis across 
multiple methods, only samples with ≥ 1400 μL of saliva were selected. The measured testosterone 
concentrations in these samples represented a wide dispersion (Minimum = 13.79 pg/mL, 25th percentile 
= 56.29 pg/mL, Median = 83.52 pg/mL, 75th percentile = 145.43 pg/mL, Maximum = 281.07 pg/mL) and 
a relatively even gender split (58% female). An in-depth description of the aliquoting, storage, and 
shipping procedures is available in the Supplemental Materials.  
2.2. Analysis with EIAs 
 Saliva samples were assayed for testosterone in-house within the Social 
Psychoneuroendocrinology Laboratory at the University of Oregon (UO) using three commonly used 
commercially-available competitive EIAs (DRG, IBL, and Salimetrics) in accordance with protocols1 and 
                                                 
1 At the request of a reviewer, we provide the analytical and functional sensitivities for DRG EIAs (1.9 pg/mL, 7.1 
pg/ml, respectively) and IBL EIAs (2.0 pg/mL, 7.6 pg/mL, respectively). The analytical sensitivity of Salimetrics 
EIAs was < 1.0 pg/mL, however Salimetrics did not provide data indicating functional sensitivity. 
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specifications provided by the manufacturers (DRG International, Inc., 2011; IBL International Corp., 
2013; Salimetrics, LLC, 2014). Samples were assayed in duplicate, and those yielding coefficients of 
variation (CVs) between duplicate wells in the highest 10% of the range were re-assayed once to 
maximize measurement accuracy (Salimetrics: CVs > 17%; IBL: CVs > 11%; DRG: CVs > 18%). After 
re-assaying the samples with the highest CVs, the average intra-assay CVs for Salimetrics, IBL, and DRG 
were 7.64%, 5.6%, and 7.8%, respectively. The average inter-assay CVs were as follows: Salimetrics: 
8.54%; IBL: 39.94%; DRG: 20.84%.2 Further, different hormones can have similar chemical structures, 
which can reduce specificity. Manufacturers test and report the cross-reactivities of a variety of analytes 
for each of their assays. We present these cross-reactivities across EIAs in the Supplemental Materials 
(see Supplemental Table S1).  
 As an additional step, the saliva samples were also analyzed for cortisol using IBL EIA kits 
(average intra-assay CV = 7.40%, average inter-assay CVs were 13.35% and 8.35% for low and high 
controls, respectively). These cortisol data allowed us to conduct secondary analyses in which we 
compared the associations of testosterone EIAs and cortisol EIAs to LC-MS/MS testosterone 
concentrations in our own study. Finally, we compared the testosterone EIA and LC-MS/MS correlations 
in our research to the correlations between EIA cortisol and LC-MS/MS cortisol found by Miller and 
colleagues (2013). This allowed us to examine whether testosterone EIAs have similar correspondence 
with LC-MS/MS values as cortisol EIAs.  
2.3. Analysis with Liquid Chromatography Tandem Mass Spectrometry 
Aliquots were analyzed for salivary testosterone and cortisol using LC-MS/MS at Oregon Health 
and Science University’s Bioanalytical Shared Resource/Pharmacokinetics Core labs. LC-MS/MS 
analysis commenced approximately 5 months after concentrations were assessed with EIAs at UO. 
Cortisol was also assessed with LC-MS/MS with the secondary goal of providing converging findings to 
                                                 
2 Although the inter-assay CVs for IBL and DRG appear high, these inter-assay CVs are consistent with those we 
have found among other data with larger sample sizes for IBL (Mean inter-assay CV = 39.57%; across 5 assays) and 
DRG (Mean inter-assay CV = 19.42%; across 19 assays). Thus, these higher inter-assay CVs appear to be stable for 
IBL and DRG EIAs.
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supplement the previously reported associated correlations between cortisol derived from EIAs and LC-
MS/MS (Miller et al., 2013). 
Salivary testosterone and cortisol were determined by LC-MS/MS following extraction with ethyl 
acetate and derivatization with the novel quaternary aminooxy (QAO) mass tag reagent, Amplifex Keto 
Reagent®, as described by Star-Weinstock et al. (2012). Testosterone (Sigma-Aldrich, St. Louis, MO) 
concentrated standards were prepared in DMSO and were diluted on the day of analysis with mass 
spectral grade water:acetonitrile (1:1) with 0.1% formic acid. The internal standard, d3-testosterone 
(Cerilliant reference standard, Sigma-Aldrich, St. Louis, MO), stock was prepared in acetonitrile and a 
working dilution prepared in methanol. Cortisol (Sigma-Aldrich, St. Louis, MO) stocks were prepared in 
1:1 DMSO:methanol and working dilutions prepared in methanol. The internal standard, d3-cortisol, 
(Cambridge Isotope Labs, Andover, MA) stock was prepared in methanol. The QAO working solution 
was prepared by adding equal volumes (0.75 mL) of the reagent and the diluent supplied in the Amplifex 
Keto reagent kit (AB Sciex, Redwood City, CA). The mixture was then further diluted with 4.5 mL of 
methanol containing 5% acetic acid to a working reagent solution of 2.5 mg/mL.  
LC-MS/MS data were acquired and analyzed using Analyst 1.6.2 software.  Sample values were 
calculated from standard curves generated from the peak area ratio of the analyte to internal standard 
versus the analyte concentration that was fit to a linear equation with 1/x weighting.  R values of the 
regression were 0.999. The lower limit of quantification for testosterone was 1 pg/mL with an accuracy of 
114% and precision (relative standard deviation) of 7.1% and the signal to noise (S/N) was 5:1. At a 
concentration of 2 pg/mL the accuracy was 109% and precision was 4.1% with a S/N of 10.5. The 
accuracy for cortisol at 50 pg/mL was 103% with a precision of 2.7% with a S/N of 30:1. 
 Standard curves were prepared by spiking 5 µL of stock solutions into 500 µL of phosphate 
buffered saline (PBS) to provide final concentrations of 1-500 pg/mL for testosterone and 50-5000 pg/mL 
for cortisol. The standards and 500 µL of saliva samples were spiked with 5 µL of an internal standard 
mixture containing d3-testosterone (1 pg/µL) and d3-cortisol (10pg/µL). The samples and standards were 
vortexed briefly and then 5 mL of ethyl acetate was added. Samples and standards were vortexed for 60 
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seconds, centrifuged at 2,000xg and the organic phase removed to a clean glass tube. The ethyl acetate 
was removed under reduced pressure using a Savant speed vacuum system. The residue was dissolved in 
50 µL QAO-reagent (2.5 mg/mL) and incubated at room temperature for 2 h. The solution was filtered 
with 0.22µ spin filters (Millipore, Billerica, MA) and placed in sample vials for analysis by LC-MS/MS 
using an injection volume of 5 µL.3 
2.4. Statistical Analytic Strategy 
Our analyses used several different techniques to both compare the measurement of testosterone 
by different EIAs and LC-MS/MS, as well as examine agreement between our EIA measures and LC-
MS/MS. In particular, we were interested in three facets of how EIAs assessments of testosterone 
correspond to those of LC-MS/MS: linear agreement, the presence of fixed and proportional bias, and 
systematic differences in the measurements of the methods. Pearson's correlations were used to examine 
linear correspondence between different kits and LC-MS/MS. Bland Altman plots (Bland & Altman, 
1986) were used to evaluate the presence of fixed bias (e.g., whether one method systematically estimates 
higher concentrations compared to the other) and proportional bias (the methods do not agree equally 
across the range of measurement) in how EIAs assess testosterone with reference to LC-MS/MS 
                                                 
3 For interested readers, we also present the instrument specifications for LC-MS/MS: Derivatized extracts were 
analyzed using a 5500 QTRAP hybrid/triple quadrupole linear ion trap mass spectrometer (AB Sciex, Redwood 
City, CA) with electrospray ionization (ESI) in positive mode. The mass spectrometer was interfaced to a Shimadzu 
(Columbia, MD) SIL-20AC XR auto-sampler and 2 LC-20AD XR LC pumps. The instrument was operated with the 
following settings: source voltage 3000 kV, GS1 50, GS2 50, CUR 15, TEM 600, and CAD gas HIGH. QAO-
testosterone and QAO-cortisol were separated on an Imtakt (Portland, OR) Cadenza CL-C18 3µ (50x2mm) column 
with matching guard column (2x10 mm) held at 35 °C in a Shimadzu CTO-20AC column oven using a gradient 
mobile phase delivered at a flow rate of 0.6 mL/min. The two solvents were, A: 0.1% formic acid in water and B: 
0.1% formic acid in acetonitrile. Initial conditions were 20% B, increased to 60% B over 3 minutes, then increased 
to 95% B held at 95% B for 2 minutes, and then decreased to start conditions over 0.1 minutes, then held at start 
conditions of 20% B for 2 minutes. Each compound formed E/Z geometric isomers that were separated with the 
gradient (Star-Weinstock et al., 2012). Testosterone eluted with retention times of 2.14 and 2.29 minutes and cortisol 
with retention times of 1.38 and 1.48 minutes. The first peak was used for quantification for each compound. 
 The multiple reaction monitoring (MRM) transitions were optimized by direct infusion of each QAO-
derivative and were as follows: QAO-testosterone, m/z 403.2→164.2 and m/z 403.2→152.1; for QAO- d3-
testosterone, m/z 406.2→164.2 and m/z 406.2→152.1; for QAO-cortisol, m/z 477.3→388.3 and m/z 477.3→358.3; 
and QAO-d3-cortisol, m/z 480.3→391.3 and m/z 480.3→361.3. Optimal intensities were obtained at a declustering 
potential of 76 V, collision energy of 59 eV, and an entrance potential of 10 V for the QAO-testosterone derivatives. 
For QAO-cortisol derivatives the optimal intensities were obtained at a declustering potential of 81 V, collision 
energy of 55 eV, and an entrance potential of 10 V. 
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testosterone. Typically, Bland Altman plots assess the correspondence between difference scores between 
two methods and the average of the two method measurements. However, because a highly accurate 
reference method was available (LC-MS/MS), we examined how differences between the concentrations 
assessed by two methods (an EIA and LC-MS/MS) were associated with LC-MS/MS testosterone 
(Krouwer, 2008). Finally, Deming regressions (Martin, 2000) were also used to compare the three EIAs 
to LC-MS/MS using the package mcr with the R statistical package (R Core Team, 2016). We regressed 
the EIA values on the LC-MS/MS reference values. This model was used to compare a regression 
equation between the EIAs and the reference method to an identity line, which assumes equality between 
the methods (Intercept = 0, Slope = 1). 
3. Results 
3.1. General Analyses 
 Descriptive statistics and correlations for all testosterone immunoassays and LC-MS/MS, as well 
as intra-assay CVs, are presented in Table 1. Although all concentrations are presented in the metric of 
pg/mL, we provide a table of our descriptive statistics presented in Table 1 in the metric of molar units 
(See Supplemental Table 2). The distributions of concentrations estimated from each of the four methods 
are presented in Figure 1. One notable finding evident in the percentiles of Table 1 is that estimated 
concentrations of testosterone varied much more considerably in the upper ranges (75th percentiles range 
from 97.69 pg/mL [DRG] to 194.89 pg/mL [IBL]) compared to the lower ranges (25th percentiles range 
from 37.46 pg/mL [DRG] to 51.86 pg/mL [Salimetrics]).  
Consistent with Table 1 and Figure 1, IBL’s testosterone concentrations showed the highest 
average concentrations and skewness, followed by Salimetrics, and then DRG. A repeated-measures 
ANOVA comparing testosterone concentrations revealed significant variability in the means of estimated 
testosterone concentrations among the four methods (Greenhouse-Geisser F(1.48, 134.62) = 43.01, p < 
.001, ηp2 = .32). Furthermore, all possible pairwise comparisons between the concentrations of each kit 
were significant using a Bonferroni correction for multiple comparisons (all ps < .001). Examining the 
means and distributions of the EIAs and LC-MS/MS revealed that all EIAs measured inflated estimates of 
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testosterone compared to LC-MS/MS. Despite having testosterone concentration estimates that were 
significantly higher than those of LC-MS/MS, the estimated concentrations from DRG EIAs were the 
most consistent with the concentrations from LC-MS/MS. 
3.2. Correlational Analyses 
We then examined the linear correlations between EIAs and LC-MS/MS testosterone 
concentrations. DRG’s concentrations were most strongly correlated with the LC-MS/MS results (r =.57), 
followed closely by Salimetrics (r=.55), and then IBL (r=.47; all ps < .001). Although Fisher’s r to Z 
transformations revealed no significant differences among these correlation coefficients (all ps ≥ .352); 
the correlations among the EIAs were higher (rs ≥ .67) than the correlations between LC-MS/MS 
testosterone and the three EIAs (rs .47 to .57). In contrast to previous research correlating cortisol EIAs to 
LC-MS/MS concentrations (rs from .90 to .97; Miller et al., 2013), our EIA and LC-MS/MS correlations 
for testosterone had considerably lower correlations between EIA Testosterone and LC-MS/MS 
Testosterone (rs .47 to .57; according to r to Z transformations, |Z|s  ≥ 6.60, ps ≤ .001). To corroborate 
correlations between testosterone EIAs and LC-MS/MS in this analysis, we also report similar 
testosterone cross-method immunoassay correlations measured in a preliminary validation study with a 
smaller sample size (N = 38) in our Supplemental Materials.  
Because we analyzed cortisol via LC-MS/MS and in previous EIA analysis of this data using IBL 
EIAs, we also calculated correlations and mean differences between these estimates to compare our 
results to Miller et al. (2013). IBL cortisol concentrations were strongly correlated with those of LC-
MS/MS (r = .76, p < .001), but less so compared to the EIA and LC-MS/MS correlations reported by 
Miller et al. (2013) using a Fisher's r to Z transformation (Zs ≥ -3.81, ps < .001), although Miller and 
colleagues (2013) did not assess cortisol with an IBL EIA.4 Consistent with Miller et al. (2013), EIA 
cortisol concentrations were also considerably higher (M = 6553.64 pg/mL, SD = 6203.27 pg/mL) than 
                                                 
4 In addition to measuring cortisol with LC-MS/MS, Miller and colleagues (2013) assessed cortisol with four EIAs 
(DRG, Salimetrics, DSL, and DELFIA) and an IBL chemiluminescence immunoassay. Our statistical comparisons 
between IBL EIAs and LC-MS/MS were to the correlations between the four EIAs and LC-MS/MS measurements 
provided by Miller and colleagues (2013). 
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those of LC-MS/MS (M = 2773.80 pg/mL, SD = 2567.99 pg/mL, t(98) = -8.49, p < .001). We also 
compared our EIA/reference method testosterone correlations to the EIA/reference method cortisol 
correlation in our own data using r to Z transformations. This revealed that the EIA to LC-MS/MS 
correlations for testosterone were all significantly lower than the correlation between IBL cortisol and 
LC-MS/MS cortisol (Zs ≥ 2.52, ps ≤ .012). Deming Regressions and Bland Altman plots also revealed 
that the IBL cortisol EIA has significant positive fixed bias and proportional bias (See Supplemental 
Materials). Collectively, our data and the results of Miller and colleagues (2013) suggest that testosterone 
EIAs have less linear correspondence with LC-MS/MS compared to cortisol EIAs. 
Furthermore, we examined correlations between EIA testosterone concentrations with those of 
LC-MS/MS in the bottom 50% and top 50% of testosterone concentrations determined by LC-MS/MS. 
We did this for two primary reasons. First, many researchers are interested in understanding testosterone 
in populations with lower levels of testosterone (e.g., women, children). Second, researchers have 
identified that quantification errors in the lower ranges of testosterone may pose a limitation to analyzing 
testosterone in low-testosterone populations (Schultheiss & Stanton, 2009). In the bottom 50% of the 
testosterone data, IBL (r = -.07) showed poor linear correspondence with LC-MS/MS testosterone 
concentrations, whereas DRG (r = .24) and Salimetrics (r = .27) were moderately associated with LC-
MS/MS concentrations. Fisher’s r to Z transformations indicated that these correlations did not 
significantly differ (ps ≥ .131), with the exception of a marginally significant difference between how LC-
MS/MS testosterone was associated with the concentrations of Salimetrics and IBL (p = .097). In the top 
50% of the data, Salimetrics (r = .31), IBL (r = .27), and DRG (r = .26) had similar moderately-sized 
linear associations with LC-MS/MS testosterone concentrations. These correlations did not significantly 
differ from each other (Fisher’s r to Z transformations, ps = .795). Although these values overall could be 
seen as suggesting that the three EIAs had only moderate correlations with those of LC-MS/MS, it is 
important to note that the range restriction introduced by median-splitting our data can restrict statistical 
power and effect sizes (Cohen, 1988). The directions and magnitude of these correlations suggest more 
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accurate assessment of low-levels of testosterone in DRG and Salimetrics, compared to IBL (See Section 
3.4 for analyses within men and women separately). 
3.3. Bland Altman Plots Across All Data 
 We used Bland Altman plots to assess the correspondence between EIA testosterone and LC-
MS/MS testosterone. Figure 2 depicts Bland Altman plots of associations between LC-MS/MS 
(abbreviated in the figure as MS to avoid appearing as a mathematical expression) and the three EIAs. 
Visual inspection of these plots indicated a degree of proportional bias for DRG and Salimetrics kits. 
DRG kits were more likely to estimate inflated values for lower testosterone concentrations, and so were 
Salimetrics kits, but to a lesser extent. Overall, all EIAs showed significant fixed bias in estimating LC-
MS/MS testosterone (95% CIs did not include 0). IBL showed the highest degree of bias (Mean 
difference = 91.06, 95% CI: [67.11, 115.00]), followed by Salimetrics (Mean difference = 51.33, 95% CI: 
[39.29, 63.36]), then DRG, which showed the least bias (Mean difference = 48.13, 95% CI: [14.12, 
33.42]).  
 To assess whether differences in assessments of measures changed as a function of average 
testosterone concentration (proportional bias), we examined associations between EIA and LC-MS/MS 
difference scores and the LC-MS/MS concentrations. There was a moderate significant association 
between the concentration differences of methods as testosterone increased for Salimetrics (r = -.25, p = 
.014) and a large association for DRG (r = -.50, p <.001), reflecting a tendency for lower concentrations 
of hormones to have inflated values from these EIAs. For IBL, there was no association between method 
differences and testosterone concentrations (r = .05, p = .647).  
3.4. Sex Differences in Agreement Trends 
We also examined if the associations presented in the Bland Altman plots (Figure 2) varied as a 
function of sex. For men, method difference scores were negatively associated with testosterone for 
Salimetrics (r = -.41, p = .007) and DRG (r = -.58, p < .001). Although the correlation was in a negative 
direction, men's IBL method difference scores were not significantly associated with testosterone (r = -
.22, p = .196). Within women, method differences were not associated with testosterone for Salimetrics (r 
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= -.14, p = .287) and DRG kits (r = -.17, p = .221). However, IBL kits showed a negative association 
between difference scores and testosterone in women (r = -.31, p = .023). Altogether, these analyses 
suggest that DRG and Salimetrics kits showed proportional bias in estimating men's testosterone, but IBL 
kits showed proportional bias in estimating women's testosterone. 
 We additionally conducted Bland-Altman plots comparing percentage differences between EIAs 
and LC-MS/MS concentrations (See Figure 3). Similar to the above analyses in Section 3.3., this analyses 
indicated that the EIAs inflated very low concentrations of testosterone (approximately <10 pg/mL) 
assessed by LC-MS/MS. This inflation of concentrations occurred in women, likely due to women having 
lower concentrations than men do. Visual inspection of this figure shows that the largest inflation of low 
concentrations occurred for IBL, whereas there was the least amount of inflation for DRG. 
3.5. Deming Regressions 
 Deming Regressions were conducted to assess correspondence between EIAs and LC-MS/MS. 
Figure 4 shows scatterplots for testosterone measured by the three EIAs compared to LC-MS/MS, as well 
as the line of best fit from Deming regressions, the identity line (intercept = 0, slope = 1), and the Deming 
regression equations. Of the three methods, DRG EIAs most closely approximated the line of identity 
(Intercept =27.00 [95% CI: 7.71, 46.30], Slope = .93 [95% CI: .66, 1.20]), followed by Salimetrics 
(Intercept = 20.70 [95% CI: 7.71, 46.30], Slope = .93 [95% CI: .66, 1.20]), and last, IBL (Intercept = -
78.95 [95% CI: -210.47, 52.57], Slope = 4.67 [95% CI: 2.83, 6.51). Additionally, although the confidence 
intervals for the slopes of DRG and Salimetrics contained the line of identity (i.e., included 1), the slope 
of IBL significantly differed from the line of identify (i.e., did not include 1). 
3.6. Additional Analyses 
Given the growing interest in testing the interactive effects (Mehta & Josephs, 2010) and 
“coupling” (Shirtcliff et al., 2015) of the HPG and HPA axes, we investigated whether the correlations 
between testosterone and cortisol concentrations from LC-MS/MS in our data differed depending on the 
EIA (i.e., IBL, Salimetrics, or DRG) used to measure testosterone. Overall, testosterone and cortisol were 
not significantly correlated across all available measures (|rs| < .08) and correlations between the cortisol 
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concentrations from LC-MS/MS concentrations and testosterone concentrations from available EIAs did 
not significantly differ (see Supplemental Materials). This suggests that the associations between 
testosterone and cortisol do not systematically differ depending on the method, be it EIAs or LC-MS/MS. 
4. Discussion 
This study compared salivary testosterone measured by frequently used EIAs to the values 
obtained from LC-MS/MS in a mixed-sex sample of healthy adults. Testosterone immunoassays from 
DRG provided assessments of salivary testosterone that were the most comparable to LC-MS/MS, 
followed closely by Salimetrics, and lastly by IBL. Consistent with previous literature, EIAs 
overestimated testosterone concentrations compared to LC-MS/MS (see Rosner et al., 2007 for a review). 
Among the three assay kits, DRG kits demonstrated the lowest estimates of testosterone concentrations, 
with Salimetrics showing higher values than DRG, and IBL showing the highest estimated concentrations 
of testosterone.  
All EIAs in the current study tended to produce more inflated testosterone concentrations in 
samples assessed as having very low testosterone by LC-MS/MS (approximately <10 pg/mL). This was 
observed exclusively within female samples, who have lower concentrations of testosterone compared to 
men. This tendency to inflate very low concentrations of testosterone creates a substantial impediment to 
accurately assessing women’s testosterone with EIAs. Researchers who are interested in studying 
testosterone in women may do so without this bias by using LC-MS/MS instead of EIAs. This systematic 
error in EIAs for assessing women’s testosterone may inflate type 2 errors by obscuring behavioral and 
psychological effects of testosterone that could be assessed with relatively decreased measurement error 
in men. In retrospect, it is possible that psychological and behavioral effects and correlates of testosterone 
identified in men but not women by EIAs (e.g., Stanton et al., 2009; Carré et al., 2013) may have been 
influenced by this elevated systematic bias for testosterone EIAs in women. 
Additionally, the analyses confirmed that cortisol measured by LC-MS/MS is similar (does not 
significantly differ) in its correlations with testosterone examined by the four methods included in this 
study. This finding is useful to future researchers interested in examining joint or concurrent effects of 
Running head: TESTOSTERONE MEASUREMENT IMMUNOASSAYS 15 
testosterone and cortisol (see Mehta & Prasad, 2015 for a review; see also Shirtcliff et al., 2015). It 
suggests that the method of testosterone measurement may not be a source of bias in investigating 
testosterone and cortisol as simultaneous predictors of psychological or behavioral outcomes. The 
increased accuracy of LC-MS/MS in assessing hormones compared to immunoassays, combined with the 
lack of method bias in immunoassays for testosterone, suggests that specific cortisol immunoassay kits 
would not influence associations between testosterone and cortisol.  
This research is not without limitations. These findings would benefit from replication with larger 
sample sizes. For instance, we found gender differences in the measurement of testosterone and the extent 
to which EIAs overestimated testosterone. Future studies with better statistical power might be able to 
better disentangle these differences at extremely low testosterone concentrations. This work would help 
clarify whether certain EIAs are more beneficial for assessing testosterone within populations with very 
low testosterone (e.g., women, children). Larger sample sizes measuring testosterone via EIAs and LC-
MS/MS are necessary to make stronger assessments of the measurement accuracy of EIAs. Another 
limitation of the current research is that the calibration consistency of LC-MS/MS could be verified more 
accurately. This research could have been improved if certified reference materials (CRM) were used for 
samples by adding CRM to the participants’ saliva samples in addition to the internal standards. The 
standard concentration samples from each kit could also have been validated with LC-MS/MS to ensure 
differences in calibrator accuracy did not affect the comparison of the methods. Finally, this study did not 
assess all commercially available methods that are available to researchers (e.g., Demeditec EIAs, 
radioimmunoassays, luminescence immunoassays).  
Altogether, our results suggested that DRG provided a closer approximation to LC-MS/MS 
testosterone data followed by Salimetrics and then IBL. However, there is considerable room for 
improvement in assessing salivary testosterone through EIAs. The testosterone EIA and LC-MS/MS 
correlations in our study have considerably less linear correspondence compared to correlations between 
EIA-measured cortisol and cortisol assessed by LC-MS/MS (Miller et al., 2013).  
5. Conclusion 
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 Altogether, the assessment of testosterone by EIAs had only moderate correspondence with 
testosterone assessed by LC-MS/MS. Based on the increasing use of LC-MS/MS for measuring hormones 
(for reviews see Soldin & Soldin, 2009 and Field, 2013), researchers may wish to adopt LC-MS/MS for 
more accurate testosterone measurement, when feasible. LC-MS/MS is more costly than conducting 
EIAs, but the advantages of LC-MS/MS to assess testosterone may outweigh the costs. In addition to 
having higher accuracy and sensitivity for hormone measurement compared to EIAs, LC-MS/MS can also 
allow for the assessment of several analytes from only one sample (e.g., Keefe et al., 2014). Based on the 
limitations of assessing testosterone through EIAs identified in this study, scientists may develop more 
accurate and affordable ways of assessing testosterone and other hormones. Improving the estimation of 
testosterone will increase precision and theoretical depth in the burgeoning research investigating 
testosterone’s role in behaviors, psychological processes, and social functioning.  
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Table 1. Descriptive statistics and intercorrelations between EIAs and LC-MS/MS testosterone concentrations. 
    LC-MS/MS Enzyme Immunoassay Concentrations   Enzyme Immunoassay Intra-assay CVs 
      Salimetrics DRG IBL   Salimetrics DRG IBL 
Moments 
        
 
Mean 48.58 99.56 71.97 141.10 
 
6.97 7.80 5.27 
 
SD 52.74 69.94 50.67 134.48 
 
3.72 6.19 3.57 
 
Skewness 
(SE) 1.34 (.24) 1.49 (.24) 1.42 (.24) 1.68 (.25) 
 
0.08 (.24) 1.14 (.24) 1.08 (.25) 
  Kurtosis (SE) 1.48 (.48) 2.48 (.48) 1.47 (.48) 2.44 (.50)   -0.13 (.48) 1.20 (.48) 1.63 (.49) 
 N 99 100 100 93     
Percentiles 
        
 
Minimum 1.10 4.94 13.22 8.88 
 
0.03 0.04 0.00 
 
1st Quartile 7.30 51.86 37.46 44.54 
 
5.16 2.82 2.74 
 
Median 19.90 78.54 53.08 87.12 
 
7.21 6.01 4.90 
 
3rd Quartile 76.20 127.80 97.69 194.89 
 
9.04 11.59 7.26 
  Maximum 238.00 374.45 236.93 596.17   16.96 30.58 18.30 
Pearson Correlations (All Samples) 
      
 
LC-MS/MS — 
       
 
Salimetrics .55** — 




DRG .57** .67** — 
  
-0.05 — 
   IBL .47** .71** .67** —   -0.16 -0.02 — 
Pearson Correlations (Men) 
      
 
LC-MS/MS — 
       
 





DRG .17 .53** — 
  
.39* — 
   IBL .10 .62** .586** —   -.03 -.01 — 
Pearson Correlations (Women, Excluding an 
Outlier)  
     
 
LC-MS/MS —   
     
 





DRG .22 .30* — 
  
-19 — 
   IBL -.17 .43** .30* —   -.25† -.02 — 
 
Note: Standard errors for Skewness and Kurtosis (SEs) are in parentheses. LC-MS/MS = Liquid chromatography 
tandem mass spectrometry, CV = coefficient of variation, SD = Standard Deviation, Levene’s Test = Levene’s 
test for the equality of variances between concentrations in the upper and lower 50% of the testosterone data. The 
metric of concentrations is pg/mL. 
†p < .10, *p<.05, **p<.001 
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Figure 1. Histograms of the distributions of testosterone concentrations (pg/mL) derived from each testosterone measurement method. 
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Figure 2. Bland Altman Plots of Testosterone EIAs and the Mass Spectrometry Reference Method. 
 
Note: The difference between EIA testosterone concentrations (Salimetrics, DRG, and IBL) and those of 
LC-MS/MS (indicated as MS on the y-axis of the figure to avoid being read as a mathematical 
expression) is drawn against the LC-MS/MS values. Solid lines indicate the mean difference in methods, 
whereas dashed lines represent the 95% limits of agreement (± 2 SDs from the mean difference). Black 
dots represent female samples, whereas white dots represent male samples.  
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Figure 3. Bland Altman Plots in the Metric of Percent Differences Between EIAs and the Mass 
Spectrometry Reference Method. 
 
Note: The percent difference between EIA testosterone concentrations (Salimetrics, DRG, and IBL) and 
those of LC-MS/MS (indicated as MS on the y-axis of the figure to avoid being read as a mathematical 
expression) is drawn against the LC-MS/MS values.   
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Figure 4. Deming regressions between LC-MS/MS and the three EIA methods. 
 
 
Note: The dashed line represents the line of identity (if DRG and LC-MS/MS concentrations were 
equivalent), whereas the blue line represents the Deming regression line. Shaded regions indicate 95% 
confidence regions for the Deming Regression line. The X-axis scaling is equivalent for all scatterplots 
and LC-MS/MS Testosterone is labeled as "Mass Spectrometry T" to avoid confusing LC-MS/MS with a 
mathematical expression when presented in equations. For interpretation of the references to color in this 
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